Literature DB >> 17276943

Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.

Kim A Janatpour1, Robert C Gosselin, William E Dager, Andrew Lee, John T Owings, Jufen Zhou, Ted Wun.   

Abstract

Heparin-induced thrombocytopenia (HIT) is a complication caused by antibodies directed to the heparin-platelet factor 4 (PF4) complex with a seemingly paradoxical high risk of thrombosis. Discontinuation of heparin and administration of an alternative anticoagulant is important in prevention of catastrophic thrombosis. Diagnosis is challenging and based on clinical probability models (Warkentin 4 Ts and Chong scale) and, to a lesser degree, laboratory testing. Enzyme-linked immunosorbent assay (ELISA) measurement of heparin-PF4 antibodies is commonly used but has low predictive values for thrombosis. We analyzed 105 cases of suspected HIT and compared optical density values and the Warkentin 4 Ts for sensitivity, specificity, positive predictive value, and negative predictive value (NPV). The predictive value of ELISA alone was inferior to the Warkentin 4 Ts score. The sensitivity and NPV of the clinical score was improved by incorporating ELISA results. The combination of a negative ELISA result with low probability 4 Ts resulted in an NPV of 94%.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276943     DOI: 10.1309/RPE753J4PMG9773Q

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia.

Authors:  Gang Zheng; Michael B Streiff; Clifford M Takemoto; Jennifer Bynum; Elise Gelwan; Jayesh Jani; Danielle Judge; Thomas S Kickler
Journal:  Clin Appl Thromb Hemost       Date:  2017-08-04       Impact factor: 2.389

2.  Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.

Authors:  Vanessa Nellen; Irmela Sulzer; Gabriela Barizzi; Bernhard Lämmle; Lorenzo Alberio
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

3.  Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia.

Authors:  Tiffany K Pon; Anjlee Mahajan; Aaron Rosenberg; Alpesh Amin; Digish Shah; Ian Jenkins; Vineet Gupta; Heather Hofmann; Anthony Bejjani; Richard White
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

Review 4.  [Heparin-induced thrombocytopenia].

Authors:  T Thiele; K Althaus; A Greinacher
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

5.  Dynamic antibody-binding properties in the pathogenesis of HIT.

Authors:  Bruce S Sachais; Rustem I Litvinov; Serge V Yarovoi; Lubica Rauova; Jillian L Hinds; Ann H Rux; Gowthami M Arepally; Mortimer Poncz; Adam Cuker; John W Weisel; Douglas B Cines
Journal:  Blood       Date:  2012-05-10       Impact factor: 22.113

6.  Usefulness of anti-PF4/heparin antibody test for intensive care unit patients with thrombocytopenia.

Authors:  Sang Hyuk Park; Seongsoo Jang; Hyoeun Shim; Geum-Borae Park; Chan-Jeoung Park; Hyun-Sook Chi; Sang-Bum Hong
Journal:  Korean J Hematol       Date:  2012-03-28

7.  Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia.

Authors:  Seon Young Kim; Hyun Kyung Kim; Kyou Sup Han; Inho Kim; Sung-Soo Yoon; Seonyang Park; Byoung Kook Kim
Journal:  Korean J Lab Med       Date:  2011-01

8.  Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test.

Authors:  Benjamin Y Lu; David Kudlowitz; Lawrence B Gardner
Journal:  J Blood Med       Date:  2015-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.